High Medicare spending on prostate cancer screenings, little benefit for older men
Friday, October 4, 2013 - 13:10
in Health & Medicine
Prostate cancer screening has little benefit for men aged 75 and older, yet over three years, the Medicare fee-for-service program spent $447 million annually on PSA-based screenings -- one-third of which was for men in the over 75 age group, according to study.